Clean Science and Technology Limited — PPTs, 06-11-2025: Investor Presentation

Clean Science & Technology reported financial results for Q2 FY26 and H1 FY26.

**Business Performance:** Standalone revenue for Q2 FY26 was 211 Cr (-7% YoY), with PAT at 65 Cr (-4% YoY). For H1 FY26, standalone revenue was 431 Cr (-3% YoY), while PAT grew 1% YoY to 141 Cr. Strong EBITDA margins (43.7% in Q2 FY26) were maintained by a favorable product mix, with Performance Chemicals (HALS series) significantly boosting its revenue share to 75% in H1 FY26.

**Growth Drivers/Strategy:** The company's strategy focuses on significant greenfield capital expenditure and new product development, particularly in high-value performance chemicals. It aims to expand its portfolio and competencies in advanced chemistries, leveraging its "clean and green chemistry" philosophy for sustainable solutions and market growth both globally and in India.

**Recent Developments:** Recent updates include ongoing chemical trials for a new performance chemical and progress on the construction of another. Notably, India's largest HALS manufacturing facility was commercialized in March 2024.

**Management Commentary/Outlook:** Management anticipates benefits from operating leverage as newly launched products scale up, ensuring future revenue growth and sustained profitability, aligning with its long-term innovation and expansion strategy.